Latest

Sep 21, 2017
Pharmaceutical Executive
Despite delay in enforcement of Drug Supply Chain Security Act's new serialization requirement, getting compliant now is key.
Sep 15, 2017
A review of a recent FSP in which the CRO partner assumed clinical monitoring and site support responsibility for more than 50 ongoing trials.
Sep 04, 2017
Lisa Kerber outlines how the pharma industry can take advantage of combining new clinical data sources such as diagnostics, or lab data, with AI to deliver on the promise of improving outcomes.
Aug 29, 2017
With a new consultation from the UK’s Department of Health proposing changes to the Statutory Scheme for Pricing of Branded Medicines, what could this mean for negotiation of a successor to the Pharmaceutical Price Regulation Scheme? Leela Barham reports.
Aug 28, 2017
A long list of high priority issues requiring immediate attention on Capitol Hill leaves little time to consider drug access proposals that have limited bipartisan support, writes Jill Wechsler.
Aug 05, 2017
Pharmaceutical Executive
For the life sciences industry in 2017, engaging across social media means less talking—and more listening. Peter Houston reports.
Jul 26, 2017
Pharma companies have been protesting expansion of the federal program that provides deeply discounted prescription drugs to certain hospitals and health providers serving low-income, uninsured patients.
Jul 16, 2017
Pharmaceutical Executive
Outlining the four core elements pharma companies need to lay the foundation for a solid digital health infrastructure.
Jul 15, 2017
Mary Ann Slack and Mitra Rocca outline how FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Jul 07, 2017
Pharmaceutical Executive
David Keane outlines four best practices in implementing AI-based technology to help achieve physician-engagement wins.
native1_300x100
lorem ipsum